Pharmaceutical Contract Manufacturing And Research Services Market Size Is Poised To Reach USD 276.8 Billion By 2028: Grand View Research Inc.

San Francisco, 24 Aug 2021: The Report Pharmaceutical Contract Manufacturing And Research Services Market Size, Share & Trends Analysis Report By Service (Manufacturing, Research), By Region, And Segment Forecasts, 2021 – 2028

The global pharmaceutical contract manufacturing and research services market size is expected to reach USD 276.8 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.75% from 2021 to 2028. The rising investments in R&D, increasing demand for generics, and the growing aging population with various chronic diseases are responsible for market growth.

The focus of large pharmaceutical companies to strategically engage with a small number of preferred providers is a meaningful solution from procurement-based outsourcing. This was one of the many business traits that this service industry has become accustomed to. Service providers that hold the potential of providing cost and quality advantages are set to make inroads and grow at a tremendous pace in the forecast period.

However, drug manufacturers are increasing their investments with respect to production capabilities. This may limit the potential growth of contract manufacturing services to traditional customers, thereby hampering industrial growth. However, the COVID-19 pandemic has provided new opportunities for pharmaceutical contract manufacturing and research services. Because of this pandemic, the contract service sector has switched its focus towards manufacturing COVID-19 therapies and vaccines. For example, 42 contract manufacturing services have publicly disclosed for 26 unique pipeline COVID-19 vaccines that they shall manufacture. The majority of vaccine manufacturers have been seen to partner with CMOs in locations, such as the U.K., the U.S., and Germany.

Access Research Report of Pharmaceutical Contract Manufacturing And Research Services Market @ https://www.grandviewresearch.com/industry-analysis/pharmaceutical-contract-manufacturing-market

Pharmaceutical Contract Manufacturing And Research Services Market Report Highlights

• By service, the manufacturing segment dominated the market in 2020. In this segment, Active Pharmaceutical Ingredient (API) / bulk drugs held the largest revenue share in 2020. Pharmaceutical companies prefer outsourcing services for API research and manufacturing owing to the reduction in the cost of production of APIs
• In the manufacturing service segment, finished dose formulations are expected to register the fastest CAGR from 2021 to 2028
• The research service segment is further segmented based on therapeutic area, wherein oncology held a significant share in 2020 and is anticipated to maintain its lead in the coming years
• CMOs/CDMOs with the ability to establish facilities in emerging countries are expected to drive the market. The contract service sector is in its infancy in countries, including Brazil. Russia, India, and China
• Companies can position themselves for strong growth, given that demand is expected to expand rapidly in the coming years.Increased competitiveness in the contract service sector is anticipated to ultimately benefit the sector growth

List of Key Players of Pharmaceutical Contract Manufacturing And Research Services Market

• Catalent
• Pharmaceutical Product Development LLC
• AbbVie
• Baxter BioPharma Solutions
• Patheon
• Grifols International, S.A.
• Dalton Pharma Services
• Boehringer Ingelheim Biopharmaceuticals GmbH
• Lonza AG

Access Press Release of Pharmaceutical Contract Manufacturing And Research Services Market @ https://www.grandviewresearch.com/press-release/global-pharmaceutical-contract-manufacturing-contract-research-market

Active Pharmaceutical Ingredients Market Size Is Expected To Reach USD 312.56 Billion By 2028: Grand View Research Inc.

San Francisco, 28 July 2021: The Report Active Pharmaceutical Ingredients Market Size, Share & Trends Analysis Report By Type Of Synthesis (Biotech, Synthetic), By Type Of Manufacturer (Captive, Merchant), By Type, By Application, By Region, And Segment Forecasts, 2021 – 2028

The global active pharmaceutical ingredients market size is expected to reach USD 312.56 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.6% from 2021 to 2028. The market is driven by the growth of the biopharmaceutical sector, advancements in active pharmaceutical ingredient (API) manufacturing, and an increase in the geriatric population.

The growth of the captive API segment is propelled by companies investing in solving challenges and developing new chemical ways for the production of APIs in house. This aids in reducing costs and the risk of contamination. Artificial intelligence and protein synthesis are expected to facilitate faster development with greater control over the process.

The rising prevalence of chronic and lifestyle-based conditions, such as cardiovascular diseases, is accelerating the demand for API. For instance, as per U.S. Pharmacist in 2020, 47% of adults have at least one risk factor that supports cardiovascular disease development. Cardiovascular diseases are one of the global, critical public health burdens driving extensive R&D for APIs in the field.

The generic API segment is gaining share in the market owing to its cost effectiveness, which helps in catering to the needs of the rising number of patients in developing regions with a low-income population. According to the Association for Accessible Medicines (AAM), in 2017, there was a considerable rise in manufacturing units in Asia, Australia, and EU5. There has also been an increase in the market share of generic drugs.

Developing nations like India are receiving an increased preference in the market over dominant API market countries, like China, owing to geopolitical situations. Furthermore, other factors favoring India include quality raw materials and products, large workforce, vast distribution network, and government subsidies under schemes like “Make in India”.

For addressing unmet medical needs, companies are collaborating to develop novel treatments. This allows firms to use their resources to aid in the development of products and enhance the supply chain. In August 2019, OmniChem Private Limited was acquired by Ajinomoto Bio-Pharma Services (earlier they were in a joint venture since 2011 for the manufacturing of APIs). The acquisition was completed in June 2020.

Access Research Report of Active Pharmaceutical Ingredients Market @ https://www.grandviewresearch.com/industry-analysis/active-pharmaceutical-ingredients-market

Active Pharmaceutical Ingredient Market Report Highlights

• According to the WHO, around 17.5 million people die each year due to cardiovascular diseases, accounting for 31% of all deaths across the globe
• The growing geriatric population in Asian countries, such as Japan and China, along with high untapped opportunities, is expected to drive the market during the forecast period. It is estimated that over 20% of the Japanese population is aged 65 and above
• According to the CDC, about 795,000 people in the U.S. suffer from stroke every year, out of which 87% cases are of ischemic stroke
• Companies are looking to diversify their API suppliers and manufacturers to different locations instead of outsourcing it to just one manufacturer or country
• Key players are increasingly focusing on vaccines, for instance, Sanofi announced an investment of USD 601.37 million for vaccine production and research in France. These investments are anticipated to drive the development of new vaccine APIs in the coming years to help facilitate readiness to deliver new products

List of Key Players of Active Pharmaceutical Ingredient Market

• Merck & Co., Inc.
• AbbVie, Inc.
• Bristol-Myers Squibb Company
• Boehringer Ingelheim International GmbH
• Cipla, Inc.
• Teva Pharmaceutical Industries Ltd.
• Albemarle Corporation
• Viatris Inc.
• Aurobindo Pharma
• Sun Pharmaceutical Industries Ltd.
• Reddy’s Laboratories Ltd.

Access Press Release of Active Pharmaceutical Ingredients Market @ https://www.grandviewresearch.com/press-release/global-active-pharmaceutical-ingredients-api-market

North America Sports Nutrition Market Projected To Exhibit Robust CAGR of 15.4% For The Forecast Period From 2021 To 2027: Grand View Research Inc.

San Francisco, 18 June 2021: The Report North America Sports Nutrition Market Size, Share & Trends Analysis Report By Product, By Application, By Formulation, By Consumer Group, By Sales Channel, By Region, And Segment Forecasts, 2021 – 2027

The North America sports nutrition market size is expected to reach USD 29.8 billion by 2027, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 15.4% from 2021 to 2027. Increasing inclination towards pursuing a healthy and active lifestyle, rising number of fitness centers and gyms in the region, and increased awareness about the importance of sports nutrition products are the key factors driving the market. According to estimates published by International Health, Racquet and Sportsclub Association (IHRSA), there has been a 27% rise in the number of health club members in the U.S., from 58 million in 2010 to 73.6 million in 2019. In addition, the rate of participation in Mexico’s 1,434 gyms and fitness centers was 3.2% of the overall population. As per Statista reports, the Canadian gym and fitness center market was valued at USD 4,300 million in 2020.

Moreover, rapidly changing lifestyles leading to an increased prevalence of chronic diseases and obesity is another key factor positively impacting market growth. As per CDC estimates, the adult obesity prevalence rate was estimated at 42.4% in 2017-2018. The rate increased from 30.5% in 1999-2000 to 42.4% in 2017-2018. As per CDC estimates for obesity prevalence in children and adolescents in 2017 – 2018, it has been stated that 21.2 % of adolescents between the age of 12-19 years are obese; 20.3% children in the age group of 6-11 years; and 13.4% children in the age group of 2-5 years are obese. Similarly, as per Statistics Canada in 2018, there were 26.8% of adults classified as obese and 36.3% of adults as overweight. Moreover, as per The Lancet estimates in 2018, 36.1% of adults were termed as obese in Mexico.

In addition, majority of the players in the market are increasingly investing in the development of new products and are continuously upgrading their existing products. The rising demand for organic and plant-based nutritional products is also contributing to market growth. Leveraging the growing trend of consuming plant-based or vegan products companies are developing products in that category. Gold Standard 100% plant-based whey protein powder of Glanbia, plc and Vega Sport Premium Protein of Vega are some of the examples of plant-based protein powders commercially available in the market.

Access Research Report of North America Sports Nutrition Market @ https://www.grandviewresearch.com/industry-analysis/north-america-sports-nutrition-market

North America Sports Nutrition Market Report Highlights

• The market is anticipated to witness significant growth over the forecast period owing to increasing inclination towards healthier lifestyles, rising number of fitness and health centers, and increasing healthcare expenditure
• The sports supplements segment dominated the market in 2020, owing to increasing consumption of supplements amongst athletes and recreational enthusiasts
• The post-workout segment dominated the market in 2020, owing to increasing consumption of nutritional products for muscle growth and recovery
• The powder segment dominated the market in 2020, owing to the fact that these formulations are easier to consume and consist of stable ingredients
• The adult consumer segment dominated the market in 2020 owing to a rise in fitness centers and gym memberships and increased healthcare expenditure
• The brick and mortar segment accounted for the largest revenue share in 2020 owing to high consumer base for the retail stores
• The U.S. dominated the market in 2020 owing to increased disposable income and rising number of gyms

List of Key Players of North America Sports Nutrition Market

• Nutrineo-Health Food Solutions
• High Performance Nutrition LLC
• Pure Natura EHF
• Abbott
• Glanbia Plc.
• Maxim Sports Nutrition
• Otsuka Pharmaceuticals
• Clif Bar & Company
• PepsiCo Foods
• Reckitt Benckiser
• Alani Nu
• Redcon 1 LLC
• Ghost
• Cellucor
• Core Nutritionals LLC
• The Genius Brand
• Kaged Muscle
• Vega
• Orgain Inc
• MUSCLEPHARM

Access Press Release of North America Sports Nutrition Market @ https://www.grandviewresearch.com/press-release/north-america-sports-nutrition-market-analysis

Active Pharmaceutical Ingredients Market Size Worth $ 312.56 Billion By 2028: Grand View Research Inc.

San Francisco, 17 Feb 2021: The Report Active Pharmaceutical Ingredients Market Size, Share & Trends Analysis Report By Type Of Synthesis (Biotech, Synthetic), By Type Of Manufacturer (Captive, Merchant), By Type, By Application, By Region, And Segment Forecasts, 2021 – 2028

The global active pharmaceutical ingredients market size is expected to reach USD 312.56 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.6% from 2021 to 2028. The market is driven by the growth of the biopharmaceutical sector, advancements in active pharmaceutical ingredient (API) manufacturing, and an increase in the geriatric population.

The growth of the captive API segment is propelled by companies investing in solving challenges and developing new chemical ways for the production of APIs in house. This aids in reducing costs and the risk of contamination. Artificial intelligence and protein synthesis are expected to facilitate faster development with greater control over the process.

The rising prevalence of chronic and lifestyle-based conditions, such as cardiovascular diseases, is accelerating the demand for API. For instance, as per U.S. Pharmacist in 2020, 47% of adults have at least one risk factor that supports cardiovascular disease development. Cardiovascular diseases are one of the global, critical public health burdens driving extensive R&D for APIs in the field.

The generic API segment is gaining share in the market owing to its cost effectiveness, which helps in catering to the needs of the rising number of patients in developing regions with a low-income population. According to the Association for Accessible Medicines (AAM), in 2017, there was a considerable rise in manufacturing units in Asia, Australia, and EU5. There has also been an increase in the market share of generic drugs.

Developing nations like India are receiving an increased preference in the market over dominant API market countries, like China, owing to geopolitical situations. Furthermore, other factors favoring India include quality raw materials and products, large workforce, vast distribution network, and government subsidies under schemes like “Make in India”.

For addressing unmet medical needs, companies are collaborating to develop novel treatments. This allows firms to use their resources to aid in the development of products and enhance the supply chain. In August 2019, OmniChem Private Limited was acquired by Ajinomoto Bio-Pharma Services (earlier they were in a joint venture since 2011 for the manufacturing of APIs). The acquisition was completed in June 2020.

Access Research Report of Active Pharmaceutical Ingredients Market @ https://www.grandviewresearch.com/industry-analysis/active-pharmaceutical-ingredients-market

Active Pharmaceutical Ingredient Market Report Highlights

• According to the WHO, around 17.5 million people die each year due to cardiovascular diseases, accounting for 31% of all deaths across the globe
• The growing geriatric population in Asian countries, such as Japan and China, along with high untapped opportunities, is expected to drive the market during the forecast period. It is estimated that over 20% of the Japanese population is aged 65 and above
• According to the CDC, about 795,000 people in the U.S. suffer from stroke every year, out of which 87% cases are of ischemic stroke
• Companies are looking to diversify their API suppliers and manufacturers to different locations instead of outsourcing it to just one manufacturer or country
• Key players are increasingly focusing on vaccines, for instance, Sanofi announced an investment of USD 601.37 million for vaccine production and research in France. These investments are anticipated to drive the development of new vaccine APIs in the coming years to help facilitate readiness to deliver new products

List of Key Players of Active Pharmaceutical Ingredient Market

• Merck & Co., Inc.
• AbbVie, Inc.
• Bristol-Myers Squibb Company
• Boehringer Ingelheim International GmbH
• Cipla, Inc.
• Teva Pharmaceutical Industries Ltd.
• Albemarle Corporation
• Viatris Inc.
• Aurobindo Pharma
• Sun Pharmaceutical Industries Ltd.
• Reddy’s Laboratories Ltd.

Access Press Release of Active Pharmaceutical Ingredients Market @ https://www.grandviewresearch.com/press-release/global-active-pharmaceutical-ingredients-api-market

Pharmaceutical Analytical Testing Outsourcing Market Expanding At A CAGR 8.3% For The Forecast Period From 2021 To 2028: Grand View Research Inc.

San Francisco, 27 Jan 2021: The Report Pharmaceutical Analytical Testing Outsourcing Market Size, Share & Trends Analysis Report By Service (Bioanalytical, Stability Testing), By Region (North America, APAC), And Segment Forecasts, 2021 – 2028

The global pharmaceutical analytical testing outsourcing market size is expected to reach USD 12.4 billion by 2028 registering a CAGR of 8.3%, according to a new report by Grand View Research, Inc. Increasing pipelines for biological candidates along with rising demand for additional analytical details on drugs as well as process development by regulatory agencies are boosting the market growth. Analytical testing helps in providing real-time product quality control along with optimizing & monitoring processes, characterize biosimilar & biologics, and improving productivity. One of the main reasons for outsourcing analytical testing services is to access skilled & experienced expertise, as well as expensive analytical equipment not available in-house.

Increasing R&D investments is one of the critical sustainability strategies. Not all companies have an infrastructure that is compatible with all types of analytical testing. Hence, outsourcing these operations is the most suitable option, which also helps save time and cost. A patent cliff largely for small molecules with the pharmaceutical industry has led to a huge dent in the pharma’s profits. In the coming years, several best-selling drugs are coming towards the end of patent life including Humira. Drug innovators are under constant pressure to launch new products. Developing advanced analytical testing to assess & monitor the quality attributes of these requires a broader set of equipment & expertise, which is beyond the internal capacity of pharma companies.

The market is developing due to increasing competition in the pharmaceutical and biopharmaceutical markets for disease-specific drugs. Most pharmaceutical manufacturing companies rely on analytical testing to help and improve productivity, optimize and monitor processes, and offer real-time product quality control. Due to this, there is an increasing demand for analytical testing outsourcing services. Hence the market is expected to show lucrative growth over the forecast period. Outsourcing of analytical testing services allows companies to handle more complex activities and focus on their core competencies. This offers cost savings by letting medical companies evade building specialized facilities and hiring staff. Pharmaceutical analytical testing includes the identification and quantification of components in therapeutic solutions or drugs.

The nature of Covid-19 transmission has led several laboratory staff members to face uncertainties, such as fears of contracting the infection along with other biosafety concerns. Thus, reduced manpower and increasing focus on the development of vaccines & therapies against Covid-19 are anticipated to negatively impact the turnaround time for routine tests. The large number of R&D activities, clinical trials, and diagnostic procedures being conducted to counteract Covid-19 is anticipated to increase the demand for analytical testing services since several pharmaceutical companies are now focusing on their core competencies and outsourcing non-core functions to increase their productivity & operational efficiency.

Access Research Report of Pharmaceutical Analytical Testing Outsourcing Market @ https://www.grandviewresearch.com/industry-analysis/pharmaceutical-analytical-testing-outsourcing-market

Pharmaceutical Analytical Testing Outsourcing Market Report Highlights

• The bioanalytical testing segment led the global market in 2020 accounting for the largest revenue share due to the high number of clinical trial registrations and entry of new participants within the market space
• The segment is also expected to register the fastest CAGR over the forecast period owing to growing R&D expenditure by pharmaceutical companies and preference for outsourcing bioanalytical testing
• The extractable and leachable services in the method development and validation segment is expected to dominate the market and register the fastest CAGR owing to an increasing number of vendors offering these services at competitive prices
• Asia Pacific is anticipated to be the fastest-growing regional market from 2021 to 2028 due to low-cost service offering by the third-party service providers in the region

List of Key Players of Pharmaceutical Analytical Testing Outsourcing Market

• SGS SA
• Toxikon, Inc.
• Eurofins Scientific
• Pace Analytical Services, Inc.
• Intertek Group Plc
• Pharmaceutical Product Development, LLC.
• WuXi AppTec, Inc.
• Boston Analytical
• Charles River Laboratories International, Inc.
• West Pharmaceutical Services Inc.

Access Press Release of Pharmaceutical Analytical Testing Outsourcing Market @ https://www.grandviewresearch.com/press-release/global-pharmaceutical-analytical-testing-outsourcing-market

U.S. Pharmaceutical Analytical Testing Outsourcing Market Size Worth $ 5.55 Billion By 2027: Grand View Research Inc.

San Francisco, 11 Dec 2020: The Report U.S. Pharmaceutical Analytical Testing Outsourcing Market Size, Share & Trends Analysis Report By Service (Bioanalytical Testing, Method Development & Validation), By End-use, And Segment Forecasts, 2020 – 2027

The U.S. pharmaceutical analytical testing outsourcing market size is expected to reach USD 5.55 billion by 2027, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.3% from 2020 to 2027. The market is mainly driven by an increasing number of clinical trial registrations, innovations in the medical industry, and the entry of new players in the market. Moreover, increasing R&D investment, growing demand for biopharmaceutical products, and rising focus on regulation, safety, and quality are some of the major factors responsible for the growth of the market. The pharmaceutical analytical testing involves outsourcing of various types of evaluation such as-

• Analytical Method Development Services
• Analytical Method Validation Services
• Bioanalytical Services / Bioanalytical Testing Services (Bioanalytical CRO)
• Pharmaceutical Biomarker Testing Services / Biomarker Services
• Preclinical Toxicology Testing Services (in vitro)
• Pharmaceutical Contract Bioavailability Testing Services
• Others

The increasing development of the pharmaceutical analytical testing services market has fascinated many new players in the industry, leading to growing competition for well established, standalone service providers. The rapid increase in the manufacturing of medications to meet the rising demand for efficient healthcare in the U.S. is projected to be one of the major factors driving the demand for pharmaceutical analytical testing outsourcing services. For example, the increasing prevalence of preventable illness and the suboptimal use of healthcare resources have led to rising demand for efficient healthcare in the U.S.

The bioanalytical testing service segment is anticipated to witness the fastest growth over the forecast period. Additionally, ancillary services such as storage, registration and testing, process and cleaning validations, and facility validation are widely being outsourced, which, in turn, is expected to help boost the market growth. Therefore, the outsourcing of analytical testing services provides quality results and is also a cost-effective solution.

Access Research Report of U.S. Pharmaceutical Analytical Testing Outsourcing Market @ https://www.grandviewresearch.com/industry-analysis/us-pharmaceutical-analytical-testing-outsourcing-market

U.S. Pharmaceutical Analytical Testing Outsourcing Market Report Highlights

• By service, the bioanalytical testing segment held the second-largest share in 2019 due to increasing preference for outsourcing analytical testing
• By end-use, pharmaceutical companies accounted for the largest share of 47.6% in 2019 owing to innovative approaches to moderate the complexity of tests
• Growing demand for biopharmaceuticals, analytical drugs, and biosimilarsis anticipated to be one of the key factors enhancing the market growth
• An increasing number of clinical trial registrations and entry of new participants in the market over the past decade are the key factors likely to propel the biopharmaceutical companies end-use segment over the forecast period

List of Key Players of U.S. Pharmaceutical Analytical Testing Outsourcing Market

• West Pharmaceutical Services, Inc.
• SGS SA
• Eurofins Scientific
• Pace Analytical Services LLC
• Intertek Group Plc
• PPD, LLC
• Wuxi AppTec, Inc.
• Boston Analytical
• Charles River Laboratories International, Inc.

Access Press Release of U.S. Pharmaceutical Analytical Testing Outsourcing Market @ https://www.grandviewresearch.com/press-release/us-pharmaceutical-analytical-testing-outsourcing-market-analysis

Women Health & Beauty Supplements Market Size Is Projected To Reach USD 68.96 Billion By 2026: Grand View Research Inc.

San Francisco, 2 Dec 2020: The Report Women Health & Beauty Supplements Market Size, Share & Trends Analysis Report By Product (Vitamins, Mineral, Enzymes, Botanicals), By Application, By Age Group, By Consumer Group, By Sales Channel, And Segment Forecasts, 2020 – 2026

The global women health and beauty supplements market size is expected to reach USD 68.96 billion by 2026, expanding at a CAGR of 4.75% over the forecast period, according to a new report by Grand View Research, Inc. Increasing intake of unhealthy, junk food along with prevalence of hormonal imbalances is resulting in increased demand for vitamin and supplements. Furthermore, growing global focus on active lifestyle and fitness is positively influencing the growth.

Rising disposable income, awareness regarding the benefits of dietary supplements, and branding aimed at targeting younger and middle-aged population is expected to significantly boost market growth. Additionally, growing focus on preventive health as a consequence of various initiatives to increase awareness about liver heath taken by public and private organizations to promote awareness regarding health will significantly boost the growth. For instance, in March 2019, a Kiss and Click campaign is launched by Amsety and Fatty Liver Foundation to increase awareness regarding liver health. The British Liver Trust is also launching various campaigns to increase awareness regarding different types of liver diseases and promoting early diagnosis.

Access Research Report of Women Health & Beauty Supplements Market @ https://www.grandviewresearch.com/industry-analysis/women-health-beauty-supplements-market

Women Health & Beauty Supplements Market Report Highlights

• In 2019, Asia Pacific was the largest regional market with a revenue share of nearly 39%, attributed to presence of a large target population base, availability of target products, and high awareness regarding active lifestyle
• By product, vitamins supplements segment held the largest revenue share in 2019. It is difficult for pregnant and breastfeeding women to get enough vitamin A, and thus specialists recommend vitamin A supplements usually in the form of retinyl acetate, beta-carotene, or a combination of preformed provitamin A
• Age 31 to 50 segment held the largest revenue share in 2019, as women in this age group are the largest consumer pool for multivitamin or mineral beauty supplements. A large portion of this population is highly influenced by social media. Thus, companies are focused on using social media platforms to promote beauty supplements as youthful and brightly packed products
• By sales channel, direct sales channel held the largest revenue share in 2019. Key factor attributed to the dominance is the presence of large players offering significant discounts and flexible payment plans

List of Key Players in the Women Health & Beauty Supplements Market

• Herbalife International of America Inc.
• GNC Holdings Inc.
• The Nature’s Bounty Co.
• Bayer AG
• Garden of life (Nestle)
• Suntory Holdings Limited
• Taisho pharmaceutical Co. Ltd.
• Swisse Wellness Pty. Ltd.
• Pharmavite LLC
• Pfizer Inc.
• Blackmores
• Fancl Corporation
• Ashahi Group Holdings
• Usana Health Sciences
• Nu Skin Enterprises
• By Health Co. Ltd
• Revital Ltd.
• The Himalaya Drug Company
• Vita Life Sciences
• Grape King Bio Ltd.
• Standard Foods Corporation

Access Press Release of Women Health & Beauty Supplements Market @ https://www.grandviewresearch.com/press-release/global-women-health-beauty-supplements-market

Allergy Immunotherapy Market Size Worth $ 3.1 Billion By 2027: Grand View Research Inc.

San Francisco, 1 Dec 2020: The Report Allergy Immunotherapy Market Size, Share & Trends Analysis Report By Treatment Type (SCIT, SLIT), By Allergy Type (Allergic Rhinitis, Asthma), By Distribution Channel, By Region, And Segment Forecasts, 2020 – 2027

The global allergy immunotherapy market size is expected to reach USD 3.1 billion by 2027 registering a CAGR of 9.0%, according to a new report by Grand View Research, Inc. Rising prevalence of allergic conditions is expected to boost the market growth. According to the statistics published by the American Academy of Allergy, Asthma & Immunology (AAAAI), global prevalence of allergic rhinitis ranges from 10% to 30%. The disease affects 7.8% of the adult population in U.S. alone.

Technological advancements in the field of bioengineering and immunology have improved the composition of allergy shots given to patients for boosting the immune system. In addition, efforts to overcome the problems associated with safety, efficacy, standardization, costs, and long duration of immunotherapy is also expected to propel the market growth in the coming years. Europe occupied the largest market share in 2019 and will retain its leading position during the forecast period. However, Asia Pacific is estimated to be the fastest-growing regional market from 2020 to 2027.

Access Research Report of Allergy Immunotherapy Market @ https://www.grandviewresearch.com/industry-analysis/allergy-immunotherapy-market

Allergy Immunotherapy Market Report Highlights

• Subcutaneous Immunotherapy (SCIT) segment generated the maximum revenue in 2019 as SCIT is the most effective and highly adopted form of allergy immunotherapy
• SCIT can be used for the treatment of a wide range of disorders including allergic rhinitis, asthma, and stinging insect hypersensitivity
• However, Sublingual Immunotherapy (SLIT) has emerged as a safe & effective alternative for SCIT
• During SLIT, the allergen is administered under the tongue in the form of tablets or drops
• Allergic rhinitis was the largest revenue-generating segment in 2019 and is estimated to maintain its dominance throughout the forecast period owing to the high disease burden across the globe
• Hospital pharmacy segment held the largest share in 2019 owing to a rise in the patient pool for treatment of allergic disorders in hospitals
• ASIT Biotech; Circassia; Mylan N.V.; Adamis Pharmaceuticals Corp.; Merck KGaA; Stallergenes Greer plc.; Allergy Therapeutics; ALK-Abelló A/S; DESENTUM OY; HAL Allergy B.V.; HollisterStier Allergy; LETIPharma; and DBV Technologies SA are the prominent participants operating in this market

List of Key Players of Allergy Immunotherapy Market

• ASIT Biotech
• Circassia
• Mylan N.V.
• Adamis Pharmaceuticals Corporation
• Merck KGaA
• Stallergenes Greer plc
• Allergy Therapeutics
• ALK-Abelló A/S
• DESENTUM OY
• HAL Allergy B.V.
• HollisterStier Allergy
• LETIPharma
• DBV Technologies SA

Access Press Release of Allergy Immunotherapy Market @ https://www.grandviewresearch.com/press-release/global-allergy-immunotherapy-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information:www.grandviewresearch.com

Pharmaceutical Logistics Market Size Worth $ 118.9 Billion By 2027: Grand View Research Inc.

San Francisco, 18 Nov 2020: The Report Pharmaceutical Logistics Market Size, Share & Trends Analysis Report By Type (Cold Chain Logistics, Non-cold Chain Logistics), By Component (Storage, Transportation), By Region, And Segment Forecasts, 2020 – 2027

The global pharmaceutical logistics market size is anticipated to reach USD 118.9 billion by 2027, expanding at a CAGR of 7.3% from 2020 to 2027, according to a new report by Grand View Research, Inc. Market development can be attributed to the rising demand for a variety of drugs as a result of increasing cases of chronic and lifestyle-related diseases. The market is expected to witness a high growth rate in cold-chain as well as non-cold chain pharmaceutical logistics owing to the impact of COVID-19 across the globe. During this pandemic situation, the government and officials across countries are primarily focusing on preventive measures and the treatment of patients. The import and export of various medicines to treat coronavirus are increasing across all the countries, including U.S. and China. Along with international trade, the nationwide logistics of drugs is also expected to increase to fulfill the rising demand from all the hospitals and medical establishments. Additionally, after the U.S. Food and Drug Administration (FDA) approved Emergency Use Authorization (EUA) for hydroxychloroquine, its trade is expected to increase in many countries, including U.S. and India. Such increased trade of drugs and medicines across countries is expected to drive the market from 2020 to 2027.

Pharmaceutical logistics is an integral part of the healthcare system, as careful handling and transportation of pharmaceutical products is of utmost importance. Therefore, equipment and staff services involved in the pharma supply chain are highly expensive. Consolidations among the pharma companies, to expand their business and global presence, is the latest trend gaining momentum in the market. Technological advancements, such as cloud-based supply chain functions and blockchain technology, which provide accurate and real-time data of operations, will also have a positive impact on market growth. Additionally, these technologies also offer predictive analytics to identify demand and supply chain optimization and risk management. Identifying risk and preventing them helps companies increase productivity, efficiency, and process optimization of their businesses.

North America accounted for the largest market share in 2019 and is expected to maintain its dominance over the forecast period. The market in Asia Pacific is projected to exhibit the highest CAGR from 2020 to 2027 owing to an increasing financial budget for the healthcare sector in several emerging countries of the region. Some of the key market participants include Agility; Air Canada; CEVA Logistics; DB Schenker; Deutsche Post AG; FedEx; LifeConEx; Marken; United Parcel Service of America, Inc.; and VersaCold Logistics Services.

Access Research Report of Pharmaceutical Logistics Market @ https://www.grandviewresearch.com/industry-analysis/pharmaceutical-logistics-market

Pharmaceutical Logistics Market Report Highlights

• Amid the pandemic, governments across the globe are emphasizing on healthcare facilities and ample medicinal supply for the patients. As such, the trade of conventional medicines is increasing from country-to-country
• FDA has approved Emergency Use Authorization (EUA) for hydroxychloroquine, which is to be used by licensed health care providers to treat teens and adults hospitalized with COVID-19, who weigh more than 50 kg. As such, the trade of hydroxychloroquine is increasing
• Many pharmaceutical companies, such as Amgen Inc.; Adaptive Biotechnologies Corp; and CalciMedica Inc., are actively engaged in the research and development of treatments for the disease. Once such novel medicines are developed and ready to be distributed across the globe, the market is expected to witness exponential growth
• Additionally, the companies, including BioNTech SE; Heat Biologics Inc.; and Pfizer Inc., are focusing on the development of the COVID-19 vaccine. The market is expected to grow at a fast pace when the vaccine is successfully developed and deployed worldwide
• The sales of cold-chain pharmaceutical products are increasing twice the rate of non-cold chain pharmaceutical products
• Outsourcing services are gaining traction in the market. Third-Party Logistics (3PL) operators offer integrating warehousing and transportation services on an outsourced basis. According to the Journal of Commerce, the revenue of the top 50 3PL companies has increased by more than 5.0% from 2014 to 2018
• Monitoring components are expected to grow at a significant share over the forecast period. This growth can be attributed to the technological advancements in the devices installed for collecting and reporting real-time shipment information
• The growing automation of refrigerated warehouses further enhances the market over the projected period. Warehouse automation includes cloud technology, robots, conveyor belts, truck loading automation, and energy management
• Political uncertainty and the rising number of natural disasters are expected to hinder market growth. The trade war between China and U.S., Brexit deal, as well as fires, floods, and hurricanes, are expected to pose as a critical challenge for the market over the next few years
• North America is expected to be the largest regional market over the next few years owing to the rising merger and acquisition activity in the region.

List of Key Players of Pharmaceutical Logistics Market

• Agility
• Air Canada
• CEVA Logistics
• DB Schenker
• Deutsche Post AG
• FedEx
• LifeConEx
• Marken
• United Parcel Service of America, Inc.
• VersaCold Logistics Services 

Access Press Release of Pharmaceutical Logistics Market @ https://www.grandviewresearch.com/press-release/global-pharmaceutical-logistics-market

Cannabidiol Market is Predicted to Observe a Tremendous Growth, With a CAGR of 22.2% From 2019 To 2025 : Grand View Research Inc.

San Francisco, 16 Nov 2020: The Report Cannabidiol Market Size, Share & Trends Analysis Report By Source Type (Hemp, Marijuana), By Distribution Channel (B2B, B2C), By End Use, By Region, And Segment Forecasts, 2019 – 2025

The global cannabidiol market size is expected to reach USD 23.6 billion, expanding at a CAGR of 22.2%, according to a new study by Grand View Research, Inc. Increasing adoption of cannabidiol (CBD) infused products in various industries such as pharmaceuticals, personal care and cosmetics, and nutraceuticals along with its medical applications is expected to drive the market over the forecast period.

The marijuana-derived CBD segment dominated the market in 2018, with a revenue of USD 3.9 billion, owing to the growing legalization of marijuana-derived products in various countries. Availability of marijuana-derived CBD products in dispensaries as well as government-approved pharmacies and stores and high efficacy of marijuana-derived CBD compared to hemp-derived CBD are some of the pivotal factors for the growth of the segment.

The Business to Consumer (B2C) segment accounted for the largest market share in 2018 and is expected to exhibit the fastest growth rate over the forecast period. Ease of availability of a wide range of CBD based products to the consumers is one of the key factors driving the growth of this segment. Furthermore, increasing adoption of cannabidiol infused pharmaceuticals for various conditions such as chronic pain, epilepsy, autism, and anxiety is anticipated to support the growth of this segment over the forecast period.

In 2018, the medical segment dominated the end-use segment, with a revenue share of 44.5%, owing to the higher adoption of cannabidiol infused products for medical purposes due to their healing properties. On the other hand, the pharmaceutical segment is expected to witness the fastest CAGR over the forecast period. Companies are focusing on manufacturing products that are intended to cure medical ailments. This key factor is anticipated to increase the demand for CBD based pharmaceuticals.

North America dominated the market in 2018 and is expected to lead the market over the forecast period owing to the legalization of cannabis and cannabis based products for medical as well as recreational purposes. Moreover, the liberalism of government regulations and increased adoption of cannabidiol for pharmaceutical, wellness, and personal use are some of the major factors driving the growth of the CBD market in this region.

Access Research Report of Cannabidiol Market @ https://www.grandviewresearch.com/industry-analysis/cannabidiol-cbd-market

Cannabidiol Market Report Highlights

• North America accounted for the largest revenue share in 2018 owing to the legalization of CBD infused products, and the presence of a significant number of players operating in this region
• The marijuana-derived CBD segment dominated the market in 2018, with a revenue of USD 3.9 billion owing to their high efficiency compared to hemp-derived CBD
• The B2C segment in CBD market is anticipated to be the fastest-growing segment over the forecast period. This is owing to high consumption of CBD based products in countries where cannabis is legal.
• In 2018, the medical segment accounted for the largest revenue share in the end-use market owing to the rising use of CBD based products for numerous medical conditions
• Some of the major players operating in cannabidiol market are ENDOCA; Isodiol International, Inc.; Medical Marijuana, Inc.; Cannoid, LLC; Elixinol; Folium Biosciences; NuLeaf Naturals, LLC; Pharmahemp d.o.o.

Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the global cannabidiol market based on source type, distribution channel, end use, and region:

Cannabidiol Source Type Outlook (Revenue, USD Million, 2014 – 2025)

• Hemp
• Marijuana

Cannabidiol Distribution Channel Outlook (Revenue, USD Million, 2014 – 2025)

• B2B
• B2C
  • Hospital Pharmacies
  • Online
  • Retail Stores

Cannabidiol End-use Outlook (Revenue, USD Million, 2014 – 2025)

• Medical
  • Chronic Pain
  • Mental Disorders
  • Cancer
  • Others
• Personal Use
• Pharmaceuticals
• Wellness
  • Food & Beverages
  • Personal Care & Cosmetics
  • Nutraceuticals
  • Others

Cannabidiol Regional Outlook (Revenue, USD Million, 2014 – 2025)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Access Press Release of Cannabidiol Market @ https://www.grandviewresearch.com/press-release/global-cannabidiol-cbd-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information:www.grandviewresearch.com